Topic in Focus

United States Adopted Names Council

United States Adopted Names (USAN)
AMA Ed Hub Logo

Learn more on prescription drug pricing from AMA Ed Hub™.
Red JAMA Logo

Learn more on prescription drug pricing from JAMA Network™.
AMA Moving Medicine podcast logo

What to know about Medicare drug price negotiation
Clear Search
·
3 Min Read

AMA, Pew research shows barriers to combating antibiotic resistance

Research highlights the need for improved antibiotic stewardship in outpatient settings to combat antibiotic resistance.

Press Releases
·
6 Min Read

July 31, 2020: National Advocacy Update

Physicians to Congress: Now is not the time for divisive surprise billing legislation and more in the latest National Advocacy Update.

Advocacy Update
Illustration - Penicillin of a doctor fending off diseases with a shield
·
4 Min Read

4 ways to address penicillin allergies to fight antibiotic resistance

A commonly encountered self-reported allergy drives unnecessary use of medication alternatives and contributes to antibiotic resistance.

Behavioral Health
·
7 Min Read

May 29, 2020: National Advocacy Update

Telehealth coverage for ERISA plans is needed and more in the latest National Advocacy Updates.

Advocacy Update
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of May 25 - 29, 2020

The news: 80 mill. babies missing vaccines, CDC guidance on antibody tests, study on asymptomatic COVID-19 patients, prescription drug supply, Dr. Harris op-ed

Publications & Newsletters
Prescription drugs
·
4 Min Read

COVID-19 casts new light on an old problem: Drug shortages

National drug shortages are chronic. Learn about the root causes and efforts to these shortages, both in the long term and during the pandemic.

Behavioral Health
UPDATED
·
4 Min Read

Joint statement on ordering, prescribing or dispensing COVID-19 medications

Organizations highlight role physicians, pharmacists and health systems play in being just stewards of health care resources during times of emergency.

Infectious Diseases
·
1 Min Read

AMA praises DEA allowing increase in controlled substance production

During COVID-19, the number of patients requiring ventilators has resulted in huge spikes in demand for controlled substances.

Press Releases
·
2 Min Read

AMA, APhA, ASHP issue joint statement about COVID-19 medications

The joint statement is in response to reports of physicians and others prophylactically prescribing, medications currently identified as potential treatments for COVID-19.

Press Releases